Business Description
PT Suparma Tbk
ISIN : ID1000054307
Total Employee Number:
833Compare
Compare
Traded in other countries / regions
SPMA.Indonesia IPO Date
1994-11-16Description
PT Suparma Tbk is an Indonesia-based company that manufactures paper and paper products. The group manufactured paper and paper wrapping products for the industrial and consumer sectors. The firm offers Laminated Wrapping Kraft, Samson Kraft, MG Paper, Coated Duplex Board, Bathroom Tissue, Carrier Tissue, Industrial Roll Towel, Kitchen Towel, and Other products. Geographically, the firm generates the majority of its revenue from the local market.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.11 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.31 | |||||
Debt-to-EBITDA | 4.32 | |||||
Interest Coverage | 5.19 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 1.83 | |||||
Beneish M-Score | -3.28 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -4.4 | |||||
3-Year EBITDA Growth Rate | -26.6 | |||||
3-Year EPS without NRI Growth Rate | -31.7 | |||||
3-Year FCF Growth Rate | -14.5 | |||||
3-Year Book Growth Rate | 5.1 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 60.31 | |||||
9-Day RSI | 62.74 | |||||
14-Day RSI | 61.31 | |||||
3-1 Month Momentum % | -9.73 | |||||
6-1 Month Momentum % | -15.7 | |||||
12-1 Month Momentum % | 2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.9 | |||||
Quick Ratio | 0.45 | |||||
Cash Ratio | 0.1 | |||||
Days Inventory | 165.69 | |||||
Days Sales Outstanding | 27.18 | |||||
Days Payable | 25.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -11.59 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 15.36 | |||||
Operating Margin % | 6.73 | |||||
Net Margin % | 3.75 | |||||
EBITDA Margin % | 6.4 | |||||
FCF Margin % | 18.14 | |||||
OCF Margin % | 22.07 | |||||
ROE % | 4.21 | |||||
ROA % | 2.89 | |||||
ROIC % | 4.47 | |||||
3-Year ROIIC % | -51 | |||||
ROC (Joel Greenblatt) % | 5.8 | |||||
ROCE % | 5.81 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 8.77 | |||||
PE Ratio without NRI | 8.69 | |||||
Shiller PE Ratio | 5.37 | |||||
Price-to-Owner-Earnings | 14.89 | |||||
PS Ratio | 0.33 | |||||
PB Ratio | 0.36 | |||||
Price-to-Tangible-Book | 0.41 | |||||
Price-to-Free-Cash-Flow | 1.8 | |||||
Price-to-Operating-Cash-Flow | 1.48 | |||||
EV-to-EBIT | 8.44 | |||||
EV-to-EBITDA | 8.02 | |||||
EV-to-Revenue | 0.51 | |||||
EV-to-FCF | 2.83 | |||||
Price-to-GF-Value | 0.92 | |||||
Price-to-Projected-FCF | 0.11 | |||||
Price-to-Graham-Number | 0.4 | |||||
| Price-to-Net-Current-Asset-Value | 2.78 | |||||
Earnings Yield (Greenblatt) % | 11.85 | |||||
FCF Yield % | 55.5 | |||||
Forward Rate of Return (Yacktman) % | 53.92 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PT Suparma Tbk Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil Rp) | 2,756,958.069 | ||
| EPS (TTM) (Rp) | 19.27 | ||
| Beta | 0.5857 | ||
| 3-Year Sharpe Ratio | -0.66 | ||
| 3-Year Sortino Ratio | -0.82 | ||
| Volatility % | 28.22 | ||
| 14-Day RSI | 61.31 | ||
| 14-Day ATR (Rp) | 6.807753 | ||
| 20-Day SMA (Rp) | 163.173077 | ||
| 12-1 Month Momentum % | 2 | ||
| 52-Week Range (Rp) | 136.923076 - 260.355029 | ||
| Shares Outstanding (Mil) | 5,330.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PT Suparma Tbk Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PT Suparma Tbk Stock Events
| Event | Date | Price (Rp) | ||
|---|---|---|---|---|
| 1.3:1 Stock Split | 2026-07-09 | 170.77 (+2.78%) | ||
| 1.3:1 Stock Split | 2025-11-10 | 217.75 (-0.54%) | ||
| 1.13:1 Stock Split | 2022-06-15 | 366.55 (+1.45%) | ||
| 1.32:1 Stock Split | 2021-06-29 | 208.27 (-3.67%) |
Show
Entries
PT Suparma Tbk Frequently Asked Questions
What is PT Suparma Tbk(ISX:SPMA)'s stock price today?
The current price of ISX:SPMA is Rp169.00. The 52 week high of ISX:SPMA is Rp260.36 and 52 week low is Rp136.92.
When is next earnings date of PT Suparma Tbk(ISX:SPMA)?
The next earnings date of PT Suparma Tbk(ISX:SPMA) is .
Does PT Suparma Tbk(ISX:SPMA) pay dividends? If so, how much?
PT Suparma Tbk(ISX:SPMA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on PT Suparma Tbk
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers